These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
215 related items for PubMed ID: 14695177
1. BCL2 accelerates inflammation-induced BALB/c plasmacytomas and promotes novel tumors with coexisting T(12;15) and T(6;15) translocations. Silva S, Kovalchuk AL, Kim JS, Klein G, Janz S. Cancer Res; 2003 Dec 15; 63(24):8656-63. PubMed ID: 14695177 [Abstract] [Full Text] [Related]
2. Functional homology between N-myc and c-myc in murine plasmacytomagenesis: plasmacytoma development in N-myc transgenic mice. Wang Y, Sugiyama H, Axelson H, Panda CK, Babonits M, Ma A, Steinberg JM, Alt FW, Klein G, Wiener F. Oncogene; 1992 Jun 15; 7(6):1241-7. PubMed ID: 1375720 [Abstract] [Full Text] [Related]
3. Insertion of Myc into Igh accelerates peritoneal plasmacytomas in mice. Park SS, Shaffer AL, Kim JS, duBois W, Potter M, Staudt LM, Janz S. Cancer Res; 2005 Sep 01; 65(17):7644-52. PubMed ID: 16140930 [Abstract] [Full Text] [Related]
7. Anaplastic, plasmablastic, and plasmacytic plasmacytomas of mice: relationships to human plasma cell neoplasms and late-stage differentiation of normal B cells. Qi CF, Zhou JX, Lee CH, Naghashfar Z, Xiang S, Kovalchuk AL, Fredrickson TN, Hartley JW, Roopenian DC, Davidson WF, Janz S, Morse HC. Cancer Res; 2007 Mar 15; 67(6):2439-47. PubMed ID: 17363561 [Abstract] [Full Text] [Related]
8. Insertion of c-Myc into Igh induces B-cell and plasma-cell neoplasms in mice. Park SS, Kim JS, Tessarollo L, Owens JD, Peng L, Han SS, Tae Chung S, Torrey TA, Cheung WC, Polakiewicz RD, McNeil N, Ried T, Mushinski JF, Morse HC, Janz S. Cancer Res; 2005 Feb 15; 65(4):1306-15. PubMed ID: 15735016 [Abstract] [Full Text] [Related]
9. E mu/S mu transposition into Myc is sometimes a precursor for T(12;15) translocation in mouse B cells. Kovalchuk AL, Kim JS, Janz S. Oncogene; 2003 May 08; 22(18):2842-50. PubMed ID: 12743607 [Abstract] [Full Text] [Related]
11. A novel c-myc-activating reciprocal T(12;15) chromosomal translocation juxtaposes S alpha to Pvt-1 in a mouse plasmacytoma. Shaughnessy J, Wiener F, Huppi K, Mushinski JF, Potter M. Oncogene; 1994 Jan 08; 9(1):247-53. PubMed ID: 8302586 [Abstract] [Full Text] [Related]
14. A retrovirus that expresses v-abl and c-myc oncogenes rapidly induces plasmacytomas. Largaespada DA, Kaehler DA, Mishak H, Weissinger E, Potter M, Mushinski JF, Risser R. Oncogene; 1992 Apr 08; 7(4):811-9. PubMed ID: 1565479 [Abstract] [Full Text] [Related]
15. Deletional remodeling of c-myc-deregulating chromosomal translocations. Kovalchuk AL, Müller JR, Janz S. Oncogene; 1997 Nov 06; 15(19):2369-77. PubMed ID: 9393881 [Abstract] [Full Text] [Related]
16. Infrequent p53 mutation in mouse tumors with deregulated myc. Gutierrez MI, Bhatia K, Siwarski D, Wolff L, Magrath IT, Mushinski JF, Huppi K. Cancer Res; 1992 Feb 15; 52(4):1032-5. PubMed ID: 1737333 [Abstract] [Full Text] [Related]
17. Nonrandom chromosomal change (trisomy 11) in murine plasmacytomas induced by an ABL-MYC retrovirus. Wiener F, Coleman A, Mock BA, Potter M. Cancer Res; 1995 Mar 01; 55(5):1181-8. PubMed ID: 7867005 [Abstract] [Full Text] [Related]
19. Ig/myc translocations of the plasmacytoma-prone BALB/c strain occur independently of the genetic and parental origin of the affected chromosomes 6, 12, and 15. Silva S, Babonits M, Klein G. Genes Chromosomes Cancer; 1996 Nov 01; 17(3):179-84. PubMed ID: 8946197 [Abstract] [Full Text] [Related]
20. Specific pathogen-free BALB/cAn mice are refractory to plasmacytoma induction by pristane. Byrd LG, McDonald AH, Gold LG, Potter M. J Immunol; 1991 Nov 15; 147(10):3632-7. PubMed ID: 1682379 [Abstract] [Full Text] [Related] Page: [Next] [New Search]